These data indicate that although K98 is reducing the parasite infection rate in HLOs, this is most likely a consequence of the HLOs losing the hepatocyte-like phenotype upon drug treatment with K98, in addition to a potential effect as a BAF inhibitor on liver-stage parasites. The gene discussed is BANF1; the disease is biological process involved in symbiotic interaction.